Ind-Swift Jammu Facility Upgrade Targets ₹100 Cr Revenue from 2029-30

Ind-Swift Laboratories Ltd is upgrading its Jammu manufacturing facility to EU-GMP/PICS standards to meet increased export demand. This upgrade, expected to be completed by early 2028 with an investment of approximately ₹45 crores, aims to generate an additional revenue of ₹100 crores from FY 2029-30 onwards from European and other regulated markets. The facility, currently WHO-GMP and ISO 9001:2008 compliant, will expand its market reach to the Rest of the World, supporting both CDMO and own branding businesses. The company recently reported strong Q1 FY27 financial results, with operating income growing 21.16% YoY and PAT (excluding exceptional items) jumping 2.04 times YoY.